Literature DB >> 27585386

Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.

Sarah L N Clarke1,2, Elizabeth J Pellowe1, Adriana A de Jesus3, Raphaela Goldbach-Mansky3, Tom N Hilliard1, Athimalaipet V Ramanan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27585386      PMCID： PMC5027210          DOI： 10.1164/rccm.201510-2102LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

1.  Stimulator of interferon genes-associated vasculitis of infancy.

Authors:  Ebun Omoyinmi; Sonia Melo Gomes; Sira Nanthapisal; Patricia Woo; Ariane Standing; Despina Eleftheriou; Nigel Klein; Paul A Brogan
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

2.  Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.

Authors:  Justine Munoz; Michel Rodière; Nadia Jeremiah; Frédéric Rieux-Laucat; Anthony Oojageer; Gillian I Rice; Flore Rozenberg; Yanick J Crow; Didier Bessis
Journal:  JAMA Dermatol       Date:  2015-08       Impact factor: 10.282

3.  Activated STING in a vascular and pulmonary syndrome.

Authors:  Y Liu; A A Jesus; B Marrero; Z Deng; M Boehm; A S Paller; D Yang; S E Ramsey; G A Montealegre Sanchez; K Tenbrock; H Wittkowski; O Y Jones; H S Kuehn; C-C R Lee; M A DiMattia; E W Cowen; B Gonzalez; I Palmer; J J DiGiovanna; A Biancotto; H Kim; W L Tsai; A M Trier; Y Huang; D L Stone; S Hill; H J Kim; C St Hilaire; S Gurprasad; N Plass; D Chapelle; I Horkayne-Szakaly; D Foell; A Barysenka; F Candotti; S M Holland; J D Hughes; H Mehmet; A C Issekutz; M Raffeld; J McElwee; J R Fontana; C P Minniti; S Moir; D L Kastner; M Gadina; A C Steven; P T Wingfield; S R Brooks; S D Rosenzweig; T A Fleisher; R Goldbach-Mansky
Journal:  N Engl J Med       Date:  2014-07-16       Impact factor: 91.245

Review 4.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

Review 5.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

Authors:  Adriana Almeida de Jesus; Scott W Canna; Yin Liu; Raphaela Goldbach-Mansky
Journal:  Annu Rev Immunol       Date:  2015-02-20       Impact factor: 28.527

Review 6.  Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review.

Authors:  Soumya D Chakravarty; Mary E Harris; Andrew M Schreiner; Mary K Crow
Journal:  Semin Arthritis Rheum       Date:  2012-05-08       Impact factor: 5.532

7.  Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations.

Authors:  Nadia Jeremiah; Bénédicte Neven; Matteo Gentili; Isabelle Callebaut; Sophia Maschalidi; Marie-Claude Stolzenberg; Nicolas Goudin; Marie-Louis Frémond; Patrick Nitschke; Thierry J Molina; Stéphane Blanche; Capucine Picard; Gillian I Rice; Yanick J Crow; Nicolas Manel; Alain Fischer; Brigitte Bader-Meunier; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

Review 8.  Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.

Authors:  Serena Slavenburg; Yvonne F Heijdra; Joost P H Drenth
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

9.  Interferon-β-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.

Authors:  Nayia Petousi; Enson C Thomas
Journal:  J Med Case Rep       Date:  2012-10-08
  9 in total
  15 in total

Review 1.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  Leaked Mitochondrial C1QBP Inhibits Activation of the DNA Sensor cGAS.

Authors:  Kun Song; Yakun Wu; Bishi Fu; Lingyan Wang; Wenzhuo Hao; Fang Hua; Yiwen Sun; Martin E Dorf; Shitao Li
Journal:  J Immunol       Date:  2021-09-15       Impact factor: 5.426

Review 3.  STING-Mediated Lung Inflammation and Beyond.

Authors:  Marie-Louise Frémond; Yanick J Crow
Journal:  J Clin Immunol       Date:  2021-02-02       Impact factor: 8.317

Review 4.  Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies.

Authors:  P Benjamin; S Sudhakar; F D'Arco; U Löbel; O Carney; C-J Roux; N Boddaert; C Hemingway; D Eleftheriou; K Mankad
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-23       Impact factor: 3.825

5.  STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.

Authors:  Xiaolei Tang; Hui Xu; Chunju Zhou; Yun Peng; Hui Liu; Jinrong Liu; Huimin Li; Haiming Yang; Shunying Zhao
Journal:  J Clin Immunol       Date:  2019-11-08       Impact factor: 8.542

Review 6.  Lung Involvement in Children with Hereditary Autoinflammatory Disorders.

Authors:  Giusyda Tarantino; Susanna Esposito; Laura Andreozzi; Benedetta Bracci; Francesca D'Errico; Donato Rigante
Journal:  Int J Mol Sci       Date:  2016-12-15       Impact factor: 5.923

7.  Protective Role of the Nucleic Acid Sensor STING in Pulmonary Fibrosis.

Authors:  Florence Savigny; Corinne Schricke; Norinne Lacerda-Queiroz; Mélanie Meda; Mégane Nascimento; Sarah Huot-Marchand; Felipe Da Gama Monteiro; Bernhard Ryffel; Aurélie Gombault; Marc Le Bert; Isabelle Couillin; Nicolas Riteau
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 8.  The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease.

Authors:  Ruihua Ma; Tatiana P Ortiz Serrano; Jennifer Davis; Andrew D Prigge; Karen M Ridge
Journal:  FASEB J       Date:  2020-08-28       Impact factor: 5.191

Review 9.  Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Authors:  Mathieu P Rodero; Yanick J Crow
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

10.  Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.

Authors:  S L N Clarke; L Robertson; G I Rice; L Seabra; T N Hilliard; Y J Crow; A V Ramanan
Journal:  Pediatr Rheumatol Online J       Date:  2020-05-12       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.